요약정보
Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatment.
- Resource Type
- Academic Journal
- Authors
- Träger M; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Schweizer L; Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.; Pérez E; Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Schmid S; Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hain EG; Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Dittmayer C; Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Onken J; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Fukuoka K; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan.; Ichimura K; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan.; Department of Brain Disease Translational Research, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Schüller U; Institute of Neuropathology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; Dührsen L; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Müther M; Department of Neurosurgery, University Hospital Münster, Münster, Germany.; Paulus W; Institute of Neuropathology, University Hospital Münster, Münster, Germany.; Thomas C; Institute of Neuropathology, University Hospital Münster, Münster, Germany.; Gutt-Will M; Department of Neurosurgery, Inselspital, Bern University Hospital, Bern, Switzerland.; Schucht P; Department of Neurosurgery, Inselspital, Bern University Hospital, Bern, Switzerland.; Maragkou T; Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland.; Schittenhelm J; Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.; Eckert F; Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.; Department of Radiation Oncology, Medical University Vienna, AKH, Comprehensive Cancer Center, Vienna, Austria.; Niyazi M; Department of Radiation Oncology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.; German Cancer Consortium (DKTK) partner site Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; Fleischmann DF; Department of Radiation Oncology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.; German Cancer Consortium (DKTK) partner site Munich, Munich, Germany.; Dorostkar MM; Center for Neuropathology, Ludwig-Maximilians-University Munich, Munich, Germany.; Feyer P; Department of Radiation Oncology, Vivantes Hospital Neukölln, Berlin, Germany.; May SA; Department of Neurosurgery, Klinikum Chemnitz, Chemnitz, Germany.; Moskopp D; Department of Neurosurgery, Vivantes Klinikum Im Friedrichshain, Berlin, Germany.; Badakhshi H; Department of Clinical Radiation Oncology, Ernst Von Bergmann Medical Center Potsdam, Potsdam, Germany.; Radke C; Department of Pathology, Ernst Von Bergmann Medical Center Potsdam, Potsdam, Germany.; Walter J; Department of Neurosurgery, Jena University Hospital, Jena, Germany.; Department of Neurosurgery, Medical Center Saarbrücken, Saarbrücken, Germany.; Ehret F; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Capper D; Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Kaul D; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Source
- Publisher:
Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN:15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE - Subject
- Language
- English